• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Integra Lifesciences (NQ: IART )

    28.68 -2.95 (-9.33%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,916,233
    Open 31.72
    Bid (Size) 28.30 (1)
    Ask (Size) 29.00 (1)
    Prev. Close 31.63
    Today's Range 27.85 - 31.72
    52wk Range 27.85 - 59.10
    Shares Outstanding 84,579,542
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
    From Pomerantz LLP
    Via GlobeNewswire
    NASDAQ:IART is probably undervalued for the fundamentals it is displaying.
    INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
    Via Chartmill

    Performance

    YTD
    -33.69%
    -33.69%
    1 Month
    -16.43%
    -16.43%
    3 Month
    -32.34%
    -32.34%
    6 Month
    -24.29%
    -24.29%
    1 Year
    -50.55%
    -50.55%

    More News

    Read More
    Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
    Via Benzinga
    NASDAQ:IART, an undervalued stock with good fundamentals.
    Via Chartmill
    Analyst Scoreboard: 5 Ratings For Integra Lifesciences
    Via Benzinga
    Recap: Integra Lifesciences Q4 Earnings
    Via Benzinga
    The Analyst Landscape: 7 Takes On Integra Lifesciences
    Via Benzinga
    The Latest Analyst Ratings for Integra Lifesciences
    Via Benzinga
    INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
    Via Benzinga
    Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    4 Analysts Have This to Say About Integra Lifesciences
    Via Benzinga
    INTEGRA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire, P.C.
    Via Business Wire
    INTEGRA LIFESCIENCES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART
    From Kahn Swick & Foti, LLC
    Via Business Wire
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Integra LifeSciences Holdings Corporation (IART)
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    INTEGRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    ROSEN, A LEADING NATIONAL FIRM, Encourages Integra LifeSciences Holdings Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important November 13 Deadline in Securities Class Action - IART
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    IART DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ: IART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Integra LifeSciences Holdings Corporation
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    Investor Notice: Deadline on November 13, 2023 Coming Up in Lawsuit Against Integra LifeSciences Holdings Corporation (NASDAQ:IART)
    Via SBWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, LEADING INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IART
    From The Rosen Law Firm PA
    Via GlobeNewswire
    INTEGRA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    ROSEN, A LEADING LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IART
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.